U.S. District Judge F. Dennis Saylor IV said that claims about the Zofran’s labeling are sufficiently specific to pass muster. Read more
The Food and Drug Administration (FDA) has delayed a rule that would regulate off-label drug and device promotion. Read more
Lawyers in our firm have handled a good number of Fosamax cases. Read more
The Biomet Comprehensive Shoulder System is the most recent example of ill-fated products haphazardly entering the market. Read more
The Low-T lawsuits were consolidated for the purpose of general pretrial discovery. Read more
The first Bair Hugger bellwether trial is currently scheduled to begin on Feb. 5, 2018. Read more
Abilify belongs to the atypical antipsychotic class of prescription drugs, and was first developed in Japan by Otsuka Pharmaceutical Co. Read more
Trial is now underway in a New Orleans Federal Court in the first Xarelto bellwether trial. Read more
Beasley Allen lawyers returned to St. Louis in early April to start our fifth talcum powder trial. Read more
The Eleventh Circuit Court of Appeals has affirmed a $2.1 million jury verdict in favor of a patient who won the first bellwether trial against Wright Medical Technology over its defective m... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.